Cargando…

Insulin resistance is an independent correlate of high serum levels of advanced glycation end products (AGEs) and low testosterone in non-diabetic men

Advanced glycation end products (AGEs) are involved in cardiovascular disease. Low testosterone level is associated with increased risks of cardiometabolic disorders as well. However, which anthropometric and metabolic variables, including AGEs, are independently correlated with low testosterone is...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tahara, Nobuhiro, Imaizumi, Tsutomu, Takeuchi, Masayoshi, Yamagishi, Sho-ichi
Formato:	Texto
Lenguaje:	English
Publicado:	Landes Bioscience 2010
Materias:	Research Papers
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2952086/ https://www.ncbi.nlm.nih.gov/pubmed/20972372 http://dx.doi.org/10.4161/oxim.3.4.12734

Ejemplares similares

Positive Association Between Serum Level of Glyceraldehyde-Derived Advanced Glycation End Products and Vascular Inflammation Evaluated by [(18)F]Fluorodeoxyglucose Positron Emission Tomography
por: Tahara, Nobuhiro, et al.
Publicado: (2012)

Cancer Malignancy Is Enhanced by Glyceraldehyde-Derived Advanced Glycation End-Products
por: Takino, Jun-Ichi, et al.
Publicado: (2010)

Atorvastatin Reduces Proteinuria in Non-Diabetic Chronic Kidney Disease Patients Partly via Lowering Serum Levels of Advanced Glycation End Products (AGEs)
por: Nakamura, Tsukasa, et al.
Publicado: (2010)

Assessment of the Concentrations of Various Advanced Glycation End-Products in Beverages and Foods That Are Commonly Consumed in Japan
por: Takeuchi, Masayoshi, et al.
Publicado: (2015)

Advanced glycation end products, oxidative stress and diabetic nephropathy
por: Yamagishi, Sho-ichi, et al.
Publicado: (2010)

Role of receptor for advanced glycation end products (RAGE) in liver disease
por: Yamagishi, Sho-ichi, et al.
Publicado: (2015)

Role of Hyperglycemia-Induced Advanced Glycation End Product (AGE) Accumulation in Atherosclerosis
por: Yamagishi, Sho-ichi, et al.
Publicado: (2018)

Relationship between Advanced Glycation End Products and Plaque Progression in Patients with Acute Coronary Syndrome: The JAPAN-ACS Sub-study
por: Fukushima, Yoshifumi, et al.
Publicado: (2013)

Predictive ability of serum advanced glycation end products at 11 to 13 weeks of gestation for early-onset preeclampsia
por: Goto, Minako, et al.
Publicado: (2022)

Pathological Role of Receptor for Advanced Glycation End Products in Calcified Aortic Valve Stenosis
por: Saku, Kosuke, et al.
Publicado: (2020)

Evidence for Toxic Advanced Glycation End-Products Generated in the Normal Rat Liver
por: Takata, Takanobu, et al.
Publicado: (2019)

DNA aptamer raised against receptor for advanced glycation end products suppresses renal tubular damage and improves insulin resistance in diabetic mice
por: Sotokawauchi, Ami, et al.
Publicado: (2021)

Neuropathy induced by exogenously administered advanced glycation end‐products in rats
por: Nishizawa, Yusuke, et al.
Publicado: (2010)

Association of advanced glycation end products, evaluated by skin autofluorescence, with lifestyle habits in a general Japanese population
por: Isami, Fumiyuki, et al.
Publicado: (2018)

Impact of intracellular glyceraldehyde-derived advanced glycation end-products on human hepatocyte cell death
por: Sakasai-Sakai, Akiko, et al.
Publicado: (2017)

Crosstalk between advanced glycation end products (AGEs)-receptor RAGE axis and dipeptidyl peptidase-4-incretin system in diabetic vascular complications
por: Yamagishi, Sho-ichi, et al.
Publicado: (2015)

Advanced glycation end products evoke endothelial cell damage by stimulating soluble dipeptidyl peptidase-4 production and its interaction with mannose 6-phosphate/insulin-like growth factor II receptor
por: Ishibashi, Yuji, et al.
Publicado: (2013)

Aqueous Extract of Glucoraphanin-Rich Broccoli Sprouts Inhibits Formation of Advanced Glycation End Products and Attenuates Inflammatory Reactions in Endothelial Cells
por: Sotokawauchi, Ami, et al.
Publicado: (2018)

Association of advanced glycation end products with sarcopenia and frailty in chronic kidney disease
por: Yabuuchi, Junko, et al.
Publicado: (2020)

Serum levels of 1,5-anhydroglucitol and 1,5-anhydrofructose-derived advanced glycation end products in patients undergoing hemodialysis
por: Tanaka, Kenji, et al.
Publicado: (2021)

Involvement of TAGE-RAGE System in the Pathogenesis of Diabetic Retinopathy
por: Takeuchi, Masayoshi, et al.
Publicado: (2010)

Advanced glycation end products potentiate citrated plasma-evoked oxidative and inflammatory reactions in endothelial cells by up-regulating protease-activated receptor-1 expression
por: Ishibashi, Yuji, et al.
Publicado: (2014)

Impact of intracellular toxic advanced glycation end-products (TAGE) on murine myoblast cell death
por: Takata, Takanobu, et al.
Publicado: (2020)

Intracellular toxic advanced glycation end-products in cardiomyocytes may cause cardiovascular disease
por: Takata, Takanobu, et al.
Publicado: (2019)

Decreased serum testosterone level was not significantly correlated with lipid indices in elderly men
por: Meftah, Neda, et al.
Publicado: (2021)

Intracellular Toxic Advanced Glycation End-Products May Induce Cell Death and Suppress Cardiac Fibroblasts
por: Takata, Takanobu, et al.
Publicado: (2022)

SAT-037 Effect of Weight on Serum Testosterone with Subcutaneous Testosterone Enanthate in Men with Testosterone Deficiency
por: Bhattacharya, Rajib, et al.
Publicado: (2020)

Acetaldehyde-Derived Advanced Glycation End-Products Promote Alcoholic Liver Disease
por: Hayashi, Nobuhiko, et al.
Publicado: (2013)

Serum glycated albumin, but not glycated hemoglobin, is low in relation to glycemia in men with hypertriglyceridemia
por: Koga, Masafumi, et al.
Publicado: (2010)

DNA-Aptamer Raised against Receptor for Advanced Glycation End Products Improves Survival Rate in Septic Mice
por: Koga, Yoshinori, et al.
Publicado: (2021)

Genetic Determinants of Serum Testosterone Concentrations in Men
por: Ohlsson, Claes, et al.
Publicado: (2011)

RasGRP2 inhibits glyceraldehyde-derived toxic advanced glycation end-products from inducing permeability in vascular endothelial cells
por: Takino, Jun-ichi, et al.
Publicado: (2021)

Generation of glyceraldehyde-derived advanced glycation end-products in pancreatic cancer cells and the potential of tumor promotion
por: Takata, Takanobu, et al.
Publicado: (2017)

Serum Levels of Growth Differentiation Factor 11 Are Independently Associated with Low Hemoglobin Values in Hemodialysis Patients
por: Yamagishi, Sho-ichi, et al.
Publicado: (2016)

N-butanol extracts of Morinda citrifolia suppress advanced glycation end products (AGE)-induced inflammatory reactions in endothelial cells through its anti-oxidative properties
por: Ishibashi, Yuji, et al.
Publicado: (2017)

Intracellular Toxic Advanced Glycation End-Products Promote the Production of Reactive Oxygen Species in HepG2 Cells
por: Sakasai-Sakai, Akiko, et al.
Publicado: (2020)

N(ω)-(Carboxymethyl)arginine Is One of the Dominant Advanced Glycation End Products in Glycated Collagens and Mouse Tissues
por: Kinoshita, Sho, et al.
Publicado: (2019)

Glucose Variability is Independently Correlated with Serum Level of Pigment Epithelium-Derived Factor in Type 2 Diabetes
por: Fujikawa, Tomoki, et al.
Publicado: (2021)

Rapid Changes in Serum Testosterone in Men With Newly Diagnosed Type 2 Diabetes With Intensive Insulin and Metformin
por: Hu, Yun, et al.
Publicado: (2021)

Protective effects of physiological testosterone on advanced glycation end product-induced injury in human endothelial cells
por: Xie, Yaping, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_3ndpv5h8u0hf5un902da3mulkj